Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny study tracks blood sugar in real life for type 2 diabetes

NCT ID NCT03436212

Knowledge-focused Sponsor: Air Liquide Santé International Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study followed 24 adults with type 2 diabetes who use insulin pumps. Participants wore a continuous glucose monitor for 14 days at home to track blood sugar levels. The goal was to see how glucose levels relate to insulin doses and meals in everyday conditions. It was purely observational and did not test any new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Continuous Glucose Monitor (CGM) device
What this could lead to
If successful, this could help doctors better understand how blood sugar levels change with insulin and meals in daily life, potentially improving diabetes management.
What could go wrong
This is a small, observational study with only 24 participants. It does not test a new treatment, so it cannot directly lead to a cure or new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Sep 2017

Finished

Mar 2018

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Selection criteria: * Type 2 Diabetes diagnosed for at least 5 years * Treated with insulin pump for at least 6 months * 7.5% ≤ HBA1c ≤ 10% (last available value dated less than 3 months) * Having given his/her free, express and informed consent to participate to the study Inclusion Criteria: * 7.5% ≤ HBA1c ≤ 10% (result of the dosage performed at selection visit) * Daily insulin requirement ≤ 1.5U/kg/day * Having been compliant to take pictures of his/her meals and snacks over the 3 days prior to the inclusion visit Non-selection/Non-inclusion criteria: * Pregnant or breastfeeding woman * Comorbidity which, in the investigator's opinion, could jeopardize the study completion * Patient with difficulties to understand the study procedures or deemed unfit, by the Investigator, to comply with operating instructions of CGM equipment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes mellitus

Contacts and locations

Locations

  • CHU de Caen, Service Endocrinologie, Diabétologie

    Caen, 14033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.